Real-time Anti-Factor Xa Measurements in Surgical Patients to Examine Enoxaparin Metabolism and Optimize Enoxaparin Dose

NCT02704052 · clinicaltrials.gov ↗

EARLY_PHASE1

Phase

COMPLETED

Status

116

Enrollment

OTHER

Sponsor class

Conditions

Deep Venous Thrombosis
Pulmonary Embolus
Venous Thromboembolism

Interventions

DRUG: Real time enoxaparin dose adjustment
DRUG: Standard enoxaparin dose

Sponsor

University of Utah